Reading a Pathology Report: A Layperson's Guide to the Structure
A pathology report — the microscope-based analysis of a biopsy or surgical specimen — is written for other doctors, not patients. But the diagnosis it contains is often the single most important piece of medical information in a patient's life. Understanding the structure helps you know where to find the diagnosis, what the grading language means, and what to ask your doctor.
The standard report structure
- Section: Clinical information · Contents: Why the biopsy was done, symptoms, prior findings
- Section: Gross description · Contents: What the specimen looked like to the naked eye
- Section: Microscopic description · Contents: What the pathologist saw under the microscope
- Section: Diagnosis / final impression · Contents: The specific finding — the sentence that matters most
- Section: Comment / note (sometimes) · Contents: Additional interpretation or recommendation
- Section: Ancillary studies · Contents: Special stains, molecular tests, IHC panel results
- Section: Pathologist name and signature · Contents: The person accountable for the reading
The diagnosis line — where to look first
Every pathology report has a final diagnosis line. Common formats:
- 'Benign — no evidence of malignancy' — reassuring.
- 'Atypia — probably benign' — some concern, follow-up needed.
- 'Dysplasia (mild / moderate / severe)' — precancerous change, grade matters.
- 'Carcinoma in situ' — very early cancer, contained; still cancer.
- 'Invasive carcinoma of type X, grade Y' — invasive cancer with specific tissue type and aggressiveness.
- 'Insufficient sample' — the biopsy did not have enough tissue; may need to repeat.
Grading language, decoded
- Well-differentiated → looks close to normal tissue; slow-growing.
- Moderately differentiated → intermediate.
- Poorly differentiated → very abnormal, often aggressive.
- Grade 1 / 2 / 3 → low / intermediate / high grade (varies by cancer type).
- Ki-67 % → percentage of dividing cells; higher means more active.
- Margins negative / positive → clean or not (after surgical removal).
Ancillary tests that matter
Modern pathology adds tests beyond H&E microscopy:
- IHC (immunohistochemistry) — stains for specific proteins that classify tumours.
- Hormone receptors (ER/PR/HER2 for breast) — guide treatment.
- Molecular tests (EGFR, KRAS, etc.) — guide targeted therapy.
- Genetic tests (MSI, HRD) — increasingly common.
These may come back as separate reports days after the main pathology. Every additional test result is a distinct piece of the puzzle and should be filed with the main report.
What to do with a positive report
- Do not read the internet before talking to your treating doctor. Pathology alone doesn't tell you prognosis — the stage does that too.
- Ask specifically: what is the diagnosis, what is the grade, what is the stage, what is the plan?
- Ask for a copy of the report, ancillary studies, and the biopsy slides for potential second opinion.
- The slides matter — the report is an opinion; the slides can be re-read by another pathologist. Ask the lab to keep them and to release them if you request a second read.
Second opinion pathology
Cancer diagnoses are correct in about 90-95% of cases on second reading; 5-10% of readings are changed at expert centres. For any significant cancer diagnosis, a second pathology opinion at a major cancer centre is a modest investment that occasionally changes the entire treatment path. This is especially worth it for less common cancers and unusual tissue types.
Store the full report, all ancillary studies, and (if possible) a copy of the slide images in your record. Cancer treatment decisions across years often reference back to the original pathology — losing that reference forces expensive re-workup.
References
Free for 90 days, no card needed. After that, keeping the record costs ₹349 for the year.
General information, not medical advice. Always talk to a qualified doctor about your own care. Where this and your doctor disagree, your doctor is right.